| 2024-01-30 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 971 0.0008% | $65.53 | $63,630 | -21.5% | |
| 2024-01-29 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 279 0.0002% | $64.14 | $17,895 | -19.54% | |
| 2024-01-23 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 7,378 0.006% | $63.69 | $469,905 | -15.95% | |
| 2024-01-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 1,607 0.0013% | $65.00 | $104,449 | -15.29% | |
| 2024-01-17 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 5,207 0.0044% | $65.58 | $341,475 | -15.72% | |
| 2024-01-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 438 0.0004% | $66.81 | $29,262 | -16.92% | |
| 2023-12-27 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 235 0.0002% | $60.23 | $14,154 | -10.21% | |
| 2023-12-26 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 68 <0.0001% | $57.86 | $3,935 | -6.74% | |
| 2023-02-23 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 1,646 0.0015% | $68.76 | $113,179 | -5.67% | |
| 2023-01-30 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 883 0.0008% | $52.76 | $46,587 | +15.58% | |
| 2023-01-23 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Development Officer | 4,479 0.004% | $51.58 | $231,027 | +18.12% |